Gene · 29949
Papers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The efficacy of metformin for the treatment of psoriasis: a meta-analysis study. | Postepy Dermatol Alergol | 2023 | 38028405 | PubTator, text mining | PubMed |
| Family aggregation and prevalence of other autoimmune diseases in SAPHO syndrome. | Heliyon | 2023 | 38027688 | PubTator, text mining | PubMed |
| Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma. | Front Pharmacol | 2023 | 38026978 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. | Oncol Rev | 2023 | 38025894 | PubTator, text mining | PubMed |
| Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma. | Transl Gastroenterol Hepatol | 2023 | 38021355 | PubTator, text mining | PubMed |
| Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2023 | 38011564 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies for psoriasis. | Signal Transduct Target Ther | 2023 | 38008779 | PubTator, text mining | PubMed |
| Inflammation and Psoriasis: A Comprehensive Review. | Int J Mol Sci | 2023 | 38003284 | PubTator, text mining | PubMed |
| Association of Asymmetric and Symmetric Dimethylarginine with Inflammation in the Population-Based Study of Health in Pomerania. | Biomolecules | 2023 | 38002294 | PubTator, text mining | PubMed |
| Resveratrol and Its Derivatives in Inflammatory Skin Disorders-Atopic Dermatitis and Psoriasis: A Review. | Antioxidants (Basel) | 2023 | 38001807 | PubTator, text mining | PubMed |
Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review. | Arthritis Res Ther | 2023 | 37986101 | PubTator, text mining | PubMed |
| Severe chronic non-bacterial osteomyelitis in combination with total MPO deficiency and responsiveness to TNFα inhibition. | Front Immunol | 2023 | 37954595 | PubTator, text mining | PubMed |
| Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations. | Brain Commun | 2023 | 37946793 | PubTator, text mining | PubMed |
| Evaluation of Laboratory Findings of Patients with Coronavirus Disease 2019 in Kerman, Iran. | Iran J Pathol | 2023 | 37942197 | PubTator, text mining | PubMed |
| VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy. | Cancer Cell Int | 2023 | 37936192 | PubTator, text mining | PubMed |
| Efficacy and safety of Duhuo-Jisheng decoction in rheumatoid arthritis: A systematic review and meta-analysis of 42 randomized controlled trials. | Medicine (Baltimore) | 2023 | 37933004 | PubTator, text mining | PubMed |
| Interleukin-19 promotes bone resorption by suppressing osteoprotegerin expression in BMSCs in a lipopolysaccharide-induced bone loss mouse model. | Bone Joint Res | 2023 | 37918438 | PubTator, text mining | PubMed |
| The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism. | Viruses | 2023 | 37896870 | PubTator, text mining | PubMed |
| IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa. | Pharmaceutics | 2023 | 37896210 | PubTator, text mining | PubMed |
| IL-20 Cytokines Are Involved in the Repair of Airway Epithelial Barrier: Implication in Exposure to Cigarette Smoke and in COPD Pathology. | Cells | 2023 | 37887308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29949/papers?page=7